Amgen (NASDAQ:AMGN) reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Amgen announced earnings per share of $4.17 on revenue of $6.16B. Analysts polled by anticipated EPS of $3.74 on revenue of $6B. That with comparison to EPS of $3.56 on revenue of $5.56B in the same period a year before. Amgen had reported EPS of $3.64 on revenue of $6.2B in the previous quarter. Analysts are expecting EPS of $3.88 and revenue of $6.33B in the upcoming quarter.
Amgen shares are down 0% from the beginning of the year , still down 2.46% from its 52 week high of $244.99 set on December 17, 2019. They are under-performing the NASDAQ 100 which is up 2.25% year to date.
Amgen shares gained 0.43% in after-hours trade following the report.
Amgen follows other major Healthcare (NYSE:HTA) sector earnings this month
Amgen's report follows an earnings beat by J&J on April 14, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B.
Pfizer had beat expectations on Tuesday with first quarter EPS of $0.8 on revenue of $12.03B, compared to forecast for EPS of $0.7 on revenue of $11.34B.
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
